Syneron Medical Ltd. (NASDAQ: ELOS) today announced a series of strategic business initiatives aimed at enhancing its corporate restructuring ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE